295 related articles for article (PubMed ID: 33796403)
1. Combination of EP
Wang Y; Cui L; Georgiev P; Singh L; Zheng Y; Yu Y; Grein J; Zhang C; Muise ES; Sloman DL; Ferguson H; Yu H; Pierre CS; Dakle PJ; Pucci V; Baker J; Loboda A; Linn D; Brynczka C; Wilson D; Haines BB; Long B; Wnek R; Sadekova S; Rosenzweig M; Haidle A; Han Y; Ranganath SH
Oncoimmunology; 2021 Mar; 10(1):1896643. PubMed ID: 33796403
[TBL] [Abstract][Full Text] [Related]
2. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.
Francica BJ; Holtz A; Lopez J; Freund D; Chen A; Wang D; Powell D; Kipper F; Panigrahy D; Dubois RN; Whiting CC; Prasit P; Dubensky TW
Cancer Res Commun; 2023 Aug; 3(8):1486-1500. PubMed ID: 37559947
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E Receptor 4 Antagonist in Cancer Immunotherapy: Mechanisms of Action.
Take Y; Koizumi S; Nagahisa A
Front Immunol; 2020; 11():324. PubMed ID: 32210957
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
[TBL] [Abstract][Full Text] [Related]
5. EP4 Antagonism by E7046 diminishes Myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunity.
Albu DI; Wang Z; Huang KC; Wu J; Twine N; Leacu S; Ingersoll C; Parent L; Lee W; Liu D; Wright-Michaud R; Kumar N; Kuznetsov G; Chen Q; Zheng W; Nomoto K; Woodall-Jappe M; Bao X
Oncoimmunology; 2017; 6(8):e1338239. PubMed ID: 28920002
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Immunotherapeutic Efficacy of Anti-PD-L1 Antibody in Combination with an EP4 Antagonist.
Sajiki Y; Konnai S; Cai Z; Takada K; Okagawa T; Maekawa N; Fujisawa S; Kato Y; Suzuki Y; Murata S; Ohashi K
Immunohorizons; 2020 Dec; 4(12):837-850. PubMed ID: 33443026
[TBL] [Abstract][Full Text] [Related]
7. Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4.
Holt DM; Ma X; Kundu N; Collin PD; Fulton AM
J Immunother; 2012; 35(2):179-88. PubMed ID: 22306906
[TBL] [Abstract][Full Text] [Related]
8. Blockade of EP4 by ASP7657 Modulates Myeloid Cell Differentiation In Vivo and Enhances the Antitumor Effect of Radiotherapy.
Nishibata T; Amino N; Tanaka-Kado R; Tsujimoto S; Kawashima T; Konagai S; Suzuki T; Takeuchi M
Biomed Res Int; 2023; 2023():7133726. PubMed ID: 38058393
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2-dependent prostaglandin E2 down-regulates intercellular adhesion molecule-1 expression via EP2/EP4 receptors in interleukin-1beta-stimulated human gingival fibroblasts.
Noguchi K; Iwasaki K; Shitashige M; Endo H; Kondo H; Ishikawa I
J Dent Res; 2000 Dec; 79(12):1955-61. PubMed ID: 11201045
[TBL] [Abstract][Full Text] [Related]
10. Endogenous prostaglandin E
Samuchiwal SK; Balestrieri B; Raff H; Boyce JA
J Biol Chem; 2017 May; 292(20):8195-8206. PubMed ID: 28341741
[TBL] [Abstract][Full Text] [Related]
11. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
[TBL] [Abstract][Full Text] [Related]
12. The influence of prostaglandin E2 on the production of IFN-γ by bovine CD4(+), CD8(+) and WC1(+) T cells.
Przybysz J; Chrostowska M; Ziółkowski H; Jaroszewski JJ; Maślanka T
Res Vet Sci; 2016 Apr; 105():31-5. PubMed ID: 27033904
[TBL] [Abstract][Full Text] [Related]
13. The prostaglandin EP4 receptor is a master regulator of the expression of PGE
Kashmiry A; Tate R; Rotondo G; Davidson J; Rotondo D
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1297-1304. PubMed ID: 30053598
[TBL] [Abstract][Full Text] [Related]
14. EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells.
Cuenca-Escalona J; Subtil B; Garcia-Perez A; Cambi A; de Vries IJM; Flórez-Grau G
Front Immunol; 2024; 15():1355769. PubMed ID: 38343540
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E₂ down-regulates the expression of CD25 on bovine T cells, and this effect is mediated through the EP4 receptor.
Maślanka T; Spodniewska A; Barski D; Jasiecka A; Zuśka-Prot M; Ziółkowski H; Markiewicz W; Jaroszewski JJ
Vet Immunol Immunopathol; 2014 Aug; 160(3-4):192-200. PubMed ID: 25001909
[TBL] [Abstract][Full Text] [Related]
16. The EP1/EP3 receptor agonist 17-pt-PGE
Theiler A; Konya V; Pasterk L; Maric J; Bärnthaler T; Lanz I; Platzer W; Schuligoi R; Heinemann A
Vascul Pharmacol; 2016 Dec; 87():180-189. PubMed ID: 27664754
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2-dependent prostaglandin (PG) E2 downregulates matrix metalloproteinase-3 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells stimulated with interleukin-1alpha.
Yan M; Noguchi K; Ruwanpura SM; Ishikawa I
J Periodontol; 2005 Jun; 76(6):929-35. PubMed ID: 15948687
[TBL] [Abstract][Full Text] [Related]
18. Binary regulation of interleukin (IL)-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1beta-stimulated human gingival fibroblasts.
Noguchi K; Shitashige M; Endo H; Kondo H; Ishikawa I
J Periodontal Res; 2002 Feb; 37(1):29-36. PubMed ID: 11842936
[TBL] [Abstract][Full Text] [Related]
19. Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy.
Peng S; Hu P; Xiao YT; Lu W; Guo D; Hu S; Xie J; Wang M; Yu W; Yang J; Chen H; Zhang X; Zhu Y; Wang Y; Yang Y; Zhu G; Chen S; Wang J; Zhang B; Chen W; Wu H; Sun Z; Ding T; Zhang H; Yi Z; Liu M; Ren S
Clin Cancer Res; 2022 Feb; 28(3):552-567. PubMed ID: 34740924
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide of Aggregatibacter actinomycetemcomitans up-regulates inflammatory cytokines, prostaglandin E2 synthesis and osteoclast formation in interleukin-1 receptor antagonist-deficient mice.
Mizutani H; Ishihara Y; Izawa A; Fujihara Y; Kobayashi S; Gotou H; Okabe E; Takeda H; Ozawa Y; Kamiya Y; Kamei H; Kikuchi T; Yamamoto G; Mitani A; Nishihara T; Noguchi T
J Periodontal Res; 2013 Dec; 48(6):748-56. PubMed ID: 23586622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]